Answers are grounded in this paper and cite their sources.
Cross-sectional study shows changes in low-dose aspirin eligibility for primary prevention in at-risk adults, highlighting the impact of updated cardiovascular thresholds.
This cross-sectional study estimates eligibility for low-dose aspirin for primary prevention based on updated Predicting Risk of Cardiovascular Disease Events risk thresholds.
No takes yet. Share an insight, caveat, or question.
Mangalesh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: